Janus kinase (JAK) 3-deficient mice were not able to reject allogeneic islet allografts. The JAK3 inhibitor 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (CAS 202475-60-3, JANEX-1, WHI-P131) prevented the rejection of islet allografts in mice with a normal JAK3 expression status. The combination of JANEX-1 and cyclosporin A (CAS 59865-13-3) was more effective than either agent alone.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
janus kinase
8
islet allografts
8
prevention islet
4
islet allograft
4
allograft rejection
4
rejection diabetic
4
diabetic mice
4
mice targeting
4
targeting janus
4
kinase 4-4'-hydroxyphenyl-amino-67-dimethoxyquinazoline
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!